60 DEGREES PHARMACEUTICALS, INC. Debt-to-equity in % from Q3 2024 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
60 Degrees Pharmaceuticals, Inc. quarterly Debt-to-equity history and growth rate from Q3 2024 to Q3 2025.
  • 60 Degrees Pharmaceuticals, Inc. Debt-to-equity for the quarter ending September 30, 2025 was 52.9 %, a 58.2% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)

60 DEGREES PHARMACEUTICALS, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 52.9 +19.5 +58.2% Sep 30, 2025
Q2 2025 42.4 Jun 30, 2025
Q1 2025 38.2 Mar 31, 2025
Q4 2024 29 Dec 31, 2024
Q3 2024 33.4 Sep 30, 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.